Surprisingly, somatic hypermutation of Ig genes also appears to be severely diminished in AID-deficient mice. The levels of SHM in IgM antibody-producing B cells is reduced 10-fold to about 1/10 3 nucleotides. The analysis was done with the use of LA-Taq polymerase, which results in an error frequency of Ͻ1/10 4 nucleotides in the 30 PCR cycles used. Thus, while some mutations were probably due to PCR errors, there could also be true SHM changes. Thus, SHM in mouse is enhanced by AID, but may not strictly require it. Perhaps additional studies with hyperimmunized mice and using a DNA polymerase, such as PFU, that creates even fewer errors will show that AID is essential.
The human AID gene has now also been sequenced IgG or IgA levels, strongly indicating that AID is essential The mice have normal B cell development, so V(D)J for CSR. Eight patients produced some IgG and two of recombination does not require AID. They respond to these also produced IgA, but at levels at least ten times immunization with specific antibody production, but the lower than age-matched controls. These may be exantibodies are all of the IgM class, whereas normally plained by residual AID activity in certain missense mutations, or a few persisting maternal B cells. other Ig classes predominate. Their germinal centers deaminase. As AID expression is restricted to germinal centers and CSR and SHM both require AID, at least in humans, it is likely that AID has very specific targets for its action. This high degree of specificity resembles that of APOBEC1, which seems to have one unique ribocytidine target in the APO-B mRNA.
The initial events in CSR, up to the production of spliced germline I-C transcripts in the , and ␥, ⑀, or ␣ loci, are normal in AID-deficient mice. Thus, the requirement for AID must be in the postulated subsequent double-strand break and break repair to join S with one of the downstream S regions. Clearly, CSR requires double-strand break repair by nonhomologous end joining as evidenced by the requirement for Ku70, Ku80, and the DNA-dependent protein kinase, SCID (Rolink et al., 1996; Casellas et al., 1998; Manis et al., 1998). These three proteins are also required for V(D)J recombination, but this process is normal in AID-deficient mice and humans. Thus, it is likely that a CSR-specific component of double-strand break repair, or of a process preceding the repair, is the target for AID. It is possible that AID acts as a DNA deaminase directly on the switch region DNA, but there is no precedent for such an activity. There is also no cogent model of how deamination of one or more C residues in the germline I-C RNAs would aid CSR. Thus, at this time there is no strong basis for suggesting that AID acts directly on the DNAs and RNAs involved in CSR. However, perhaps the most likely step for AID action in CSR is in the creation of the doublestrand breaks in the S and downstream S region DNA sequences. AID may be required for modification by cytidine deamination of the mRNAs encoding one or for AID. The deaminase specificity of APOBEC-1 is determined by a cofactor, ACF (Mehta et al., 2000) . Likewise, AID, which contains the catalytic site for deaminaSomatic hypermutation was also investigated in extion, may require a cofactor that is specific for editing pressed IgM genes in peripheral blood of five of the the mRNA of the nuclease(s) responsible for the breaks patients. Two had no mutations, compared with 2.6% in CSR. One would postulate then, that the combination to 6.3% of nucleotides mutated in the variable region of AID and its cofactor would cause deamination of one in control subjects. Three had significant, albeit low, or more C residues in the CSR nuclease mRNA(s) and levels of SHM. Two of these also showed some CSR, that this editing would be required for the production suggesting perhaps residual AID activity as noted of the active nuclease(s). In analogy to the editing of above.
Apo ., 1991b) . Thus,
